2012
DOI: 10.3233/jad-2011-111307 View full text |Buy / Rent full text
|
|

Abstract: Neprilysin-2 (NEP2), a close homolog of neprilysin (NEP), degrades amyloid-β (Aβ) and serves an important role in clearing Aβ in vivo. We measured NEP2 and NEP mRNA levels from non-impaired (NI), mild cognitive impaired (MCI), and clinical Alzheimer’s disease (AD) subjects in the mid-temporal gyrus, mid-frontal gyrus, caudate, and cerebellum. NEP2 activity levels were also determined. Our results indicate that NEP2 and NEP mRNA expression is altered in MCI subjects relative to NI subjects in AD-susceptible reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
13
1
2

Publication Types

Select...

Relationship

0
0

Authors

Journals